NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp. operates as a medical technology company. It focuses on development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from brain related disorders. The company was founded on August 20, 2009 and is headquartered in Minnetonka, MN.

As of 10/15/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  06/27/2013
Outstanding shares:  12,010,019
Average volume:  209,048
Market cap:   $36,030,057
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -4.58
PB ratio:   4.06
PS ratio:   17.52
Return on equity:   -88.89%
Net income %:   -382.78%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy